Lipigon Pharmaceuticals (Sweden) Technical Analysis
| LPGO Stock | SEK 0.17 0.01 6.25% |
As of the 28th of November, Lipigon Pharmaceuticals secures the Mean Deviation of 5.08, risk adjusted performance of (0.06), and Standard Deviation of 7.34. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Lipigon Pharmaceuticals, as well as the relationship between them.
Lipigon Pharmaceuticals Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Lipigon, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to LipigonLipigon |
Lipigon Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Lipigon Pharmaceuticals Technical Analysis
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Lipigon Pharmaceuticals volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Lipigon Pharmaceuticals Trend Analysis
Use this graph to draw trend lines for Lipigon Pharmaceuticals AB. You can use it to identify possible trend reversals for Lipigon Pharmaceuticals as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Lipigon Pharmaceuticals price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Lipigon Pharmaceuticals Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Lipigon Pharmaceuticals AB applied against its price change over selected period. The best fit line has a slop of 0.0023 , which may suggest that Lipigon Pharmaceuticals AB market price will keep on failing further. It has 122 observation points and a regression sum of squares at 0.2, which is the sum of squared deviations for the predicted Lipigon Pharmaceuticals price change compared to its average price change.About Lipigon Pharmaceuticals Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Lipigon Pharmaceuticals AB on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Lipigon Pharmaceuticals AB based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Lipigon Pharmaceuticals price pattern first instead of the macroeconomic environment surrounding Lipigon Pharmaceuticals. By analyzing Lipigon Pharmaceuticals's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Lipigon Pharmaceuticals's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Lipigon Pharmaceuticals specific price patterns or momentum indicators. Please read more on our technical analysis page.
Lipigon Pharmaceuticals November 28, 2024 Technical Indicators
Most technical analysis of Lipigon help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Lipigon from various momentum indicators to cycle indicators. When you analyze Lipigon charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.06) | |||
| Market Risk Adjusted Performance | (0.46) | |||
| Mean Deviation | 5.08 | |||
| Coefficient Of Variation | (1,118) | |||
| Standard Deviation | 7.34 | |||
| Variance | 53.88 | |||
| Information Ratio | (0.11) | |||
| Jensen Alpha | (0.83) | |||
| Total Risk Alpha | (1.77) | |||
| Treynor Ratio | (0.47) | |||
| Maximum Drawdown | 36.83 | |||
| Value At Risk | (7.69) | |||
| Potential Upside | 11.76 | |||
| Skewness | 1.72 | |||
| Kurtosis | 5.13 |
Additional Tools for Lipigon Stock Analysis
When running Lipigon Pharmaceuticals' price analysis, check to measure Lipigon Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lipigon Pharmaceuticals is operating at the current time. Most of Lipigon Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Lipigon Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lipigon Pharmaceuticals' price. Additionally, you may evaluate how the addition of Lipigon Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.